FIRST EXPERIMENT:

aeth.science

Think,
create and
fund science

aeth.science® is a pioneering platform where AI and community-driven research combine to speed up scientific discovery through decentralized science. We bring together researchers, citizen scientists, and token holders to collaboratively design, fund, and implement cutting-edge experiments, revolutionizing the path to scientific breakthroughs.

Where AI and Citizen Scientists Co-Create the Future of DESCI

Click to watch

Potential Research Niches

Microbiome Research Neurodegenerative Research Ocean Conservation

Microbiome Research

Studying the human gut microbiome and its impact on health, disease, and longevity.

  • High Impact: The gut microbiome is linked to a wide range of conditions, including obesity, diabetes, mental health, and autoimmune diseases.
  • Emerging Field: Microbiome research is still in its early stages, with many discoveries yet to be made.
  • Scalable Experiments: Microbiome studies can start with simple lab experiments and scale to human trials.

Neurodegenerative Diseases

Studying neurodegenerative diseases like Alzheimer's, Parkinson's, and ALS to identify potential treatments.

  • High Impact: Neurodegenerative diseases affect millions of people worldwide, with few effective treatments available.
  • Scalable Experiments: Research can start with simple lab experiments and scale to animal and human trials.
  • Commercial Potential: Discoveries can be licensed to pharmaceutical companies or used to develop new therapies.

Ocean Conservation

Developing and testing solutions for ocean conservation, such as coral reef restoration, marine biodiversity monitoring, or plastic pollution mitigation.

  • Global Relevance: Oceans are critical to the planet's health, but they face threats like coral bleaching, overfishing, and pollution.
  • Scalable Experiments: Research can start with lab experiments and scale to field trials.
  • Commercial Potential: Discoveries can be licensed to environmental companies or used to create new conservation tools.

Implementation Phases

1

AI-Scientist Collaboration

  • AI analyzes existing datasets and collaborates with scientists and citizen scientists to draft novel research proposals
  • The AI acts as a co-pilot, suggesting innovative approaches and uncovering hidden patterns in data
aeth.science AI Research Assistant
DR
Dr. Roberts Just now

I've noticed an unusual pattern in the microbiome diversity data between age groups 30-35. Can you analyze this further?

AI
AI Copilot Just now

I've analyzed the pattern and discovered a significant correlation. Let me visualize this for you.

Age-Specific Microbiome Pattern

96.3% Confidence

This suggests a unique bacterial composition that could be linked to stress response mechanisms. Would you like me to cross-reference this with recent publications?

DR
Dr. Roberts Just now

Yes, please do. Also, can you suggest potential experimental approaches to validate this?

AI
AI Copilot Just now

I've found 3 relevant papers and generated an experimental design. Here's my suggestion:

Proposed Experiment
Novelty: 92%
1 Longitudinal sampling of 50 subjects aged 30-35
2 Weekly stress hormone measurements
3 Metagenomic sequencing with strain-level resolution
🧬
89.3% Pattern Match
+12.4%
🔬
0.003 p-value
Significant
🧮
0.78 Correlation
Strong
2

Token Launch and Funding

  • Research proposals are tokenized, and a new token is launched to represent the experiment
  • The community funds the experiment by purchasing tokens
  • Gamified challenges drive engagement and innovation
aeth.science Token Platform
🧫 Yeast
$RAP
Rapamycin
Life Extension 28.14%
Market Cap $6.2M
Created by
0xAe8...F3b2
9/21/2024
🦠 Bacteria
$MET
Metformin
Life Extension 23.76%
Market Cap $4.9M
Created by
0x7Dc...9eA4
9/21/2024
🐟 Fish
$SPE
Spermidine
Life Extension 19.82%
Market Cap $3.8M
Created by
0x4Bf...2cD8
9/21/2024
3

Experiment Execution & Review

  • Experiments are executed with live data streaming to the platform
  • Token holders track progress and vote on next steps
  • Decentralized peer review system validates research
  • AI provides real-time insights from streaming data
aeth.science Experiment Dashboard

Live Experiment Data

Streaming
Control Group Treatment Group
98.2% Data Quality
1,248 Data Points
24.6% Variance
AI Analysis
92% Confidence

Significant positive correlation detected between treatment and target outcome (p < 0.001). Recommend continuing current protocol.

Peer Review & Governance

JD
Dr. Jane Doe Neuroscience, Stanford
9.2

Methodology is sound and data collection protocols are well-implemented. Statistical analysis shows promising early results.

75%
Approval Rate
324 Total Votes
89K Tokens Staked
Next Decision Point
48h 32m Until Phase 2 Vote
4

IP Ownership & Monetization

  • Token holders own the rights to the intellectual property generated
  • Community can vote to license IP to manufacturers
  • Option to reinvest proceeds in further research
aeth.science IP Management
🧬

AETH-CURE...777 IP Portfolio

3 Patents Pending 2 Active Licenses
Ξ 324.5K
+12.4% this month
Patent Application
Pending
Novel Microbiome Composition for Cognitive Enhancement

Unique bacterial strain combination showing significant improvement in memory and learning capabilities.

89% Novelty Score
Ξ 180K Estimated Value
Active License
Revenue Generating
Bacterial Culture Production Method

Optimized fermentation process for large-scale production of therapeutic bacterial strains.

Ξ 45K Monthly Revenue
3/5 Years Remaining

IP Governance

2 Active Proposals
Voting Active
23h 45m left
License Agreement: PharmaCo Therapeutics

Proposed 5-year exclusive license for therapeutic applications in North America.

Upfront Payment Ξ 500K
Royalty Rate 4.5%
Territory North America
72% Approval 324/450 votes
Reinvestment Pool
Ξ 285.3K
Research 60%
Development 25%
Reserve 15%

Our Team

We are a group of researchers and scientists from top academic laboratories, bringing together expertise in biology, AI, and blockchain technology. United by our passion for democratizing science, we're building aeth.science to transform how scientific discoveries are made.

Roadmap

Our strategic roadmap outlines the key phases and milestones for building and scaling the Aeth.science platform. From initial platform launch to expansion into multiple research verticals, each phase is carefully planned to ensure successful delivery of our vision.

The roadmap spans from Q1 2025 onwards, with clear milestones for platform development, research execution, and ecosystem expansion.

Q1 2025

Platform Launch & Initial Research

  • Launch aeth.science V1 platform with AI research assistant
  • Open first round of microbiome research proposals
  • Establish core scientific advisory board
  • Release token and begin community building
Q1 2025

First Research Cohort

  • Launch V2 platform with experiment platform
  • Select and fund first three microbiome experiments
  • Begin live data streaming from initial lab studies
  • Launch decentralized peer review system
  • Implement gamified community challenges
Q2 2025

Scaling & Validation

  • Complete first round of lab experiments
  • Begin model organism studies for successful projects
  • Establish key research partnerships
Q3 2025 & Beyond

Growth & Expansion

  • Launch IP licensing framework
  • Begin preparation for expansion into second research vertical
  • Launch research monetization framework
  • Scale institutional partnerships
  • Expand into additional research verticals
  • Begin human trials for successful projects